Sono-Tek Corporation (NASDAQ: SOTK) — FY2024 Form 10-K
Reporting period: Fiscal year ended February 29, 2024; comparisons are with the fiscal year ended February 28, 2023. Although the request references 2023 Q4, this filing reports full-year results, not standalone quarterly results.
Business context
Sono-Tek designs and manufactures custom ultrasonic coating systems used in microelectronics/electronics, medical, alternative energy, industrial, and research markets. It sells through direct staff, distributors, and representatives; 45% of FY2024 sales were outside the U.S. and Canada. The company reported 94 employees and manufactures at its Milton, New York facility.
Financial performance and liquidity
| Metric | FY2024 | FY2023 | Change |
|---|---|---|---|
| Net sales | $19.700 million | $15.058 million | +31% |
| Gross profit | $9.845 million | $7.652 million | +29% |
| Gross margin | 50.0% | 50.8% | -0.8 percentage points |
| Operating income | $1.182 million | $683,000 | +73% |
| Net income | $1.441 million | $636,000 | +127% |
| Basic and diluted EPS | $0.09 | $0.04 | — |
| Cash from operating activities | $1.164 million | $1.325 million | Down $161,000 |
- Operating expenses rose 24% to $8.662 million, including R&D expense of $2.886 million, or 14.6% of sales.
- Interest and dividend income was $530,000, versus $140,000; a $32,000 unrealized securities gain brought total interest, dividend, and unrealized investment income to approximately $562,000.
- At year-end, cash and cash equivalents were $2.135 million and marketable securities were $9.711 million, totaling $11.847 million, up $402,000. Working capital was $12.123 million, up $1.006 million.
- No borrowings were outstanding. The company had a $1.5 million revolving line, with $1.428 million unused after $72,000 was used to secure letters of credit. It also disclosed a $750,000 equipment-purchase facility.
- Inventory increased to $5.222 million from $3.243 million. The company attributed much of the increase to growth-related needs, supply-chain delays, and production for large FY2025 orders.
- Capital spending was $795,000. Cash used in investing activities was $2.384 million, largely reflecting net purchases of marketable securities.
Changes and business drivers
- Alternative/Clean Energy sales grew 96% to $5.997 million; Industrial sales rose 48% to $3.606 million and Medical sales rose 13% to $4.180 million.
- Multi-Axis Coating Systems sales increased 48% to $10.075 million, while Integrated Coating Systems sales increased 159% to $2.889 million. Fluxing Systems sales fell 39% and OEM Systems sales fell 28%, partly reversing unusually high prior-year PCB-related sales.
- U.S. and Canada sales rose 60% to $10.878 million; EMEA rose 26%. Asia Pacific was nearly flat and Latin America declined 21%.
- Total reported backlog at year-end was $9.277 million, including $9.079 million of equipment backlog and $198,000 of services-related backlog. The company began including services backlog in its reported total.
Outlook, commentary, risks, and unusual items
- The filing gives no specific quantified revenue or earnings guidance. Management said three additional production-scale systems for a solar-market customer, valued at $730,000 each, remained in backlog and were scheduled to ship in FY2025.
- Management expects the shift of certain completed-development labor from R&D to manufacturing costs to continue to affect reported gross margin, with a similar annual impact anticipated in FY2025. The reclassification reduced FY2024 fourth-quarter gross margin by approximately 2%, without changing overall financial performance.
- A California sales-tax review covering sales since April 1, 2019 led to a $138,000 estimated reserve for tax, penalties, and interest. The balance sheet separately reports $152,547 of accrued sales tax; the filing text does not clearly reconcile these amounts.
- Principal risks include order timing and the absence of long-term customer purchase commitments; customer and receivable concentration; dependence on a single manufacturing facility; component availability and production capacity; international, geopolitical, inflation, and labor-market risks; competition and technology change; and intellectual-property and cybersecurity risks.
- The CEO and President role transferred to R. Stephen Harshbarger effective January 1, 2024; Christopher Coccio became Executive Chairman. Management concluded disclosure controls and internal control over financial reporting were effective. The auditor gave an unqualified opinion on the financial statements and reported no critical audit matters; it did not express an opinion on internal-control effectiveness.
- The company reported no pending legal actions, no material commitments or contingencies other than disclosed letters of credit, and no off-balance-sheet arrangements. It reported $1.819 million of cash above the FDIC-insured limit.
Important facts for investors to verify
- Whether the three large clean-energy systems ship in FY2025 as scheduled, and whether backlog converts to recognized revenue and cash.
- Whether elevated inventory levels, supply constraints, and production capacity affect deliveries, cash generation, or margins.
- The amount and eventual outcome of the California sales-tax exposure, including the difference between the stated $138,000 estimate and $152,547 accrued sales-tax balance.
- Whether clean-energy growth is sustained and offsets weaker PCB-related product demand; also monitor customer concentration and international sales exposure.
- How the labor-cost reclassification and product mix affect comparable gross margins in FY2025.